The epigenetic function of androgen receptor in prostate cancer progression

Androgen and androgen deprivation (castration) therapies, including androgen receptor antagonists, are clinically used to treat patients with prostate cancer. However, most hormone-dependent prostate cancer patients progress into a malignant state with loss of hormone-dependency, known as castration...

Descripción completa

Detalles Bibliográficos
Autores principales: Sawada, Takahiro, Kanemoto, Yoshiaki, Kurokawa, Tomohiro, Kato, Shigeaki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Cell and Developmental Biology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10070878/
https://www.ncbi.nlm.nih.gov/pubmed/37025180
http://dx.doi.org/10.3389/fcell.2023.1083486

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10070878/
https://www.ncbi.nlm.nih.gov/pubmed/37025180
http://dx.doi.org/10.3389/fcell.2023.1083486

Ejemplares similares